Clinical Trials Browser

INDUSTRY × Has results × Metastatic Castration-Resistant Prostate Cancer × Clear all

NCT02116582 2024-12-06

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Phase 4 Completed

215 enrolled 11 charts

Metastatic Castration-Resistant Prostate Cancer

NCT03414034 2024-11-07

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

72 enrolled 21 charts

Metastatic Castration-Resistant Prostate Cancer

NCT04408924 2024-06-25

CYCLONE 1

Phase 2 Completed

44 enrolled 21 charts

Metastatic Castration-Resistant Prostate Cancer